KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.93

SafeHeal Colovac Colorectal Anastomosis Protection Device evaluation (SAFE-2) pivotal study: an international randomized controlled study to evaluate the safety and effectiveness of the Colovac Colorectal Anastomosis Protection Device.

Elisabeth Hain, Jérémie H Lefèvre, Alison Ricardo, Sang Lee, Karen Zaghiyan, Elisabeth McLemore, Danny Sherwinter, Rebecca Rhee, Matthew Wilson, Joseph Martz, Justin Maykel, John Marks, Jorge Marcet, Philippe Rouanet, Leon Maggiori, Niels Komen, Nicolas De Hous, Zaher Lakkis, Jean-Jacques Tuech, Fadi Attiyeh, Eddy Cotte, Patricia Sylla

Colorectal Dis 26(6) 1271-1284

PMID38750621
PMCID-
DOI10.1111/codi.17012
发表日期2024-05-15
入排依据:干预为非药物单独策略,未满足药物干预要求。
摘要

摘要

AIM: Although proximal faecal diversion is standard of care to protect patients with high-risk colorectal anastomoses against septic complications of anastomotic leakage, it is associated with significant morbidity. The Colovac device (CD) is an intraluminal bypass device intended to avoid stoma creation in patients undergoing low anterior resection. A preliminary study (SAFE-1) completed in three European centres demonstrated 100% protection of colorectal anastomoses in 15 patients, as evidenced by the absence of faeces below the CD. This phase III trial (SAFE-2) aims to evaluate the safety and effectiveness of the CD in a larger cohort of patients undergoing curative rectal cancer resection. METHODS: SAFE-2 is a pivotal, multicentre, prospective, open-label, randomized, controlled trial. Patients will be randomized in a 1:1 ratio to either the CD arm or the diverting loop ileostomy arm, with a recruitment target of 342 patients. The co-primary endpoints are the occurrence of major postoperative complications within 12 months of index surgery and the effectiveness of the CD in reducing stoma creation rates. Data regarding quality of life and patient's acceptance and tolerance of the device will be collected. DISCUSSION: SAFE-2 is a multicentre randomized, control trial assessing the efficacy and the safety of the CD in protecting low colorectal anastomoses created during oncological resection relative to standard diverting loop ileostomy. TRIAL REGISTRATION: NCT05010850.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。